Back to search

National and Kapodistrian University of Athens

Ανοσοϊστοχημική μελέτη του αυξητικού χόνδρου σε οστεοχονδροδυσπλασίες και φυσιολογικά οστά κατά την εμβρυϊκή και περιγεννητική ηλικία

Abstract

dc:description

IntroductionSkeletal dysplasias are a clinically and genetically heterogenous group of malformations concerning the bones and/or cartilage. Their clinical presentation varies from mild growth retardation of postnatal death. Although skeletal dysplasias are individually rare, collectively they make up a large group of disorders. Their molecular background is complex and is being studied intensively. Studies with animal models have implicated, among others, Insulin-like Growth Factor (IGF)-1 and Growth Hormone (GH) in the longitudinal bone growth during both the embryonic and neonatal period. However, their potential role in skeletal dysplasias has not been elucidated yet.AimThe aim of the present study was to investigate the immunohistochemical expression of IGF-1 and GH in the long bones of 3 groups fetuses: Fetuses with normal longitudinal bone growth, fetuses suffering from genetic skeletal disorders which affect the longitudinal bone growth and fetuses with intrauterine growth retardation (IUGR) of genetic or other cause, in order to establish whether IGF-1 and GF are implicated in the long bone growth disorders of any cause. Materials and MethodsImmunohistochemistry was performed on paraffin-embedded tissue specimens from long bones (femoral head and, in cases, tibial as well) of 23 fetuses with normal growth, 29 fetuses suffering from genetic skeletal disorders and 24 fetuses with IUGR to detect the proteins IGF-1 and GH. Statistic analysis was based on parametric and non parametric methods.ResultsGH was not immunodetected in the cartilage of the growth plate. On the contrary, IGF-1 was immunodetected in the chordrocytes of both the calm and proliferative zone, as well as in osteoblasts, osteoclasts and bone marrow cells. IGF-1 immunoexpressions in the various zones of the cartilage were positively correlated with each other within each one of the groups we studied. On the contrary, IGF-1 immunostaining was inversely correlated with the gestational age in the control and the IUGR groups. Moreover, IGF-1 immunoexpression was found to be statistically different between the groups. Specifically, the most intense IGF-1 immunodetection was found in the healthy fetuses, the IUGR group depicted less intense immunoexpression, while the skeletal dysplasias had the least intense labeling. Taking into consideration the gestational age as well, IGF-1 immunoexpression was found to be significantly different in the 1st and 2nd trimester in the proliferative zone, in perivascu150 lar areas and in the total cartilage. Regarding the subgroups of genetic skeletal disorders, IGF-1 immunostaining was found to be significantly higher in osteogenesis imperfect in sub-perichondral and perivascular areas. No correlation was found between IGF-1 and the patients’ sex, the lethality of the disorder and the histological appearance of the cartilage.DiscussionIn the present study, IGF-1 was immunodetected in all cartilage zones, as well as in the chondrocytes of the perichondrium, osteoblasts, osteoclasts and bone marrow cells. This immunolocalization has never been described before in human fetuses, while findings from animal models are controversial. To our knowledge, this is the first study to report an inverse correlation between IGF- 1 immunoexpression in the cartilage and gestational age within both the control and IUGR groups. This finding agrees with experimental data from animal models. In the groups of skeletal dysplasias, the inverse trend between IGF-1 and gestational age was not statistically significant, possibly because IGF-1 immunoexpression is too low, already from the 1st trimester, to show statistically significant correlations. The fact that IGF-1 immunostaining was found to be more intense in the control group than in the skeletal dysplasias and IUGR supports the pivotal role of IGF-1 in the linear bone growth. Morevover, the statistically significant difference in the IGF-1 immunoexpression only in the growth plate between the control group and the dysplasias, control group and IUGR and between dysplasias and IUGR, depicts the importance of the IGF-1 action in that particular zone. With regard to the IGF-1 immunoexpression in the three groups in relation to the trimesters, we found significant difference in the IGF-1 immunoepxression in the growth plate, which was not present in the calm zone. The aforementioned differences were found during the 1st and 2nd trimesters when the fetal development is quicker and more intense while they were not present during the 3d trimester. In the present study, the most frequent skeletal disorder was that of thanatophoric dysplasia type 1, which belongs to the group of FGFR-3 mutations. FGFR-3 is mainly expressed in the growth plate, which agrees with our previously reported findings. The difference in the IGF-1 expression in the subperichondrial and perivascular regions in the subgroup of the osteogenesis imperfect in relation to the rest subgroups, where it was lower, could possibly be attributed to the fact that osteogenesis imperfecta is a disorder characterized by decreased bone mineralization due to mutations in the gene of the collagen 1α1. In other words, the linear bone growth is intact but the limb ends up shortened due to fractures and deformities. Concluding, especially in healthy fetuses and to a lesser extent in the fetuses suffering from skeletal disorders and those with IUGR, the local expression of IGF-1 in the cartilage of the humerus bone is being decreased in relation with gestational age. IGF-1 immunoexpression in healthy fetuses was found to be significantly higher than both fetuses with skeletal dysplasias or IUGR, which depicts its pivotal role in linear bone growth. The fact that the most intense difference in the IGF-1 expression between control group and the two other groups was observed in the growth plate agrees with the important role of the growth plate in the longitudinal bone growth.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Agrogiannis, Georgios
  • Αγρογιάννης, Γεώργιος

Subjects

dc:subject × 14

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40311

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Agrogiannis, Georgios; Αγρογιάννης, Γεώργιος. Ανοσοϊστοχημική μελέτη του αυξητικού χόνδρου σε οστεοχονδροδυσπλασίες και φυσιολογικά οστά κατά την εμβρυϊκή και περιγεννητική ηλικία. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/40311